Title: Prof' Santosh K' Mishra
1Information Driven Biomedicine
- Prof. Santosh K. Mishra
- Executive Director, BII
- CIAPR IV Shanghai, May 21 2004
2What/How
RNA
3Complexity of Data
Information
The Genetic Code
DNA
RNA
Proteins
Pathways
Complexity
4Bioinformaticians Will Be Busy Bees
- Precise, predictive model of transcription
initiation and termination ability to predict
where and when transcription will occur in a
genome - Precise, predictive model of RNA
splicing/alternative splicing ability to predict
the splicing pattern of any primary transcript in
any tissue - Determining effective proteinDNA, proteinRNA
and proteinprotein recognition codes - Precise, quantitative models of signal
transduction pathways ability to predict
cellular responses to external stimuli - Accurate ab initio protein structure prediction
At a bioinformatics conference last fall, EBIs
Ewan Birney, MITs Chris Burge, and
GlaxoSmithKlines Jim Fickett gave an impromptu
roundup of the future challenges of the field.
Burge polished them up for GT
5Human Genes by General Function
- Incomplete List of parts
- No assembly instructions
Science Feb 16 2001 1304-1351
Unknown Genes
6Bioinformaticians Will Be Busy Bees
- Precise, predictive model of transcription
initiation and termination ability to predict
where and when transcription will occur in a
genome - Precise, predictive model of RNA
splicing/alternative splicing ability to predict
the splicing pattern of any primary transcript in
any tissue - Determining effective proteinDNA, proteinRNA
and proteinprotein recognition codes - Precise, quantitative models of signal
transduction pathways ability to predict
cellular responses to external stimuli - Accurate ab initio protein structure prediction
At a bioinformatics conference last fall, EBIs
Ewan Birney, MITs Chris Burge, and
GlaxoSmithKlines Jim Fickett gave an impromptu
roundup of the future challenges of the field.
Burge polished them up for GT
7The Evolution Of High Resolution Biology
8Pioneers
- Hartwell et al (1999) Nature 402, C47-C52
- We need to develop simplifying, higher level
models and find general principles that will
allow us to grasp and manipulate the function of
biochemical networks
9Genes to Targets to Pathways to Systemic
Physiology
10The Hierarchy Of Biological Organization The
Post Genome Initiative Era
Genes All The
Genes Will Be Identified
Proteins
The Proteome Will Be The Focus
Organelles Cells
Tissues Organs
Organisms
Disease Physiology
11Hartwell et al (1999)
- A useful theory must
- Provide realistic, accurate, predictive
simulations of complex biochemical networks, and - Reveal general principles by which proteins
control the adaptive behavior of cells
12Systems Biology
- Application Integration
- Modeling, Simulation, Hypothesis Generation
- Map data to molecules, bio-chemical process,
- and diseases
Technology Integration Annotation, Functionation,
License, Literature, Visualization
13- What do we understand ?
- Biological chemistry, Transmission of genetic
information
What we dont understand ? Biological
complexity The best non-living equivalent of life
(for in-silico modeling) Emergent phenomena
14- Why in-silico modeling ?
- What-if questions ?
- Essential vs. redundant
- Rejection of false hypothesis
- Prediction of future systems behavior
- Perform experiments at will !
Why mathematical modeling?
- Advantages, limitations, problems
- Quantitative vs. qualitative
15Our Modeling strategy
Conceptual Model
Analytical Model
Computer simulation
Match in-silico in-vivo
16Bioinformaticians Will Be Busy Bees
- Precise, predictive model of transcription
initiation and termination ability to predict
where and when transcription will occur in a
genome - Precise, predictive model of RNA
splicing/alternative splicing ability to predict
the splicing pattern of any primary transcript in
any tissue - Determining effective proteinDNA, proteinRNA
and proteinprotein recognition codes - Precise, quantitative models of signal
transduction pathways ability to predict
cellular responses to external stimuli - Accurate ab initio protein structure prediction
At a bioinformatics conference last fall, EBIs
Ewan Birney, MITs Chris Burge, and
GlaxoSmithKlines Jim Fickett gave an impromptu
roundup of the future challenges of the field.
Burge polished them up for GT
17Architectural finesse
18(No Transcript)
19Bioinformaticians Will Be Busy Bees
- Biomarkers discovery
- Rational design of small molecule inhibitors of
proteins - Mechanistic understanding of protein evolution
understanding exactly how new protein functions
evolve - Mechanistic understanding of speciation
molecular details of how speciation occurs - Continued development of effective gene
ontologies systematic ways to describe the
functions of gene or protein - Education development of appropriate
bioinformatics curricula for secondary,
undergraduate, and graduate education
20Biomarkers
- A characteristics that is objectively
measured and evaluated as an indicator of normal
biological processes, pathogenic processes, or
pharmacologic response(s) to a therapeutic
intervention - NIH/FDA Biomarkers Definitions Working
Group in 1999. - Three types of biomarkers
- Disease biomarkers - used to monitor and diagnose
the progression of a disease - Drug efficacy/toxicity biomarkers - used to
monitor the efficacy or toxicity of a treatment
regime - PD marker for pharmacologic response
21Biomarkers
- A biomarker needs to be linked with a clinical
endpoint - Clinical endpoint is defined as how patient
feels, functions or survives - Biomarkers needs to be validated for sensitivity,
specificity, and reproducibility - Biomarker can be any anatomical, histological,
physiological, molecular measurements such as a
gene, protein, metabolite, SNP, brain image, cell
count, etc. - Can even be a mathematical equation
- It is very rare for a single marker to have both
sensitivity and specificity linked to an end point
22Biomarkers
- A dynamic relationship between effector gene and
gene, protein and protein, metabolite and
metabolite as described by mathematical equations
is a better biomarker, albeit with great
challenge in experimental design and explanation.
- It is well-documented that even for the same
class of drug one can have different surrogate
markers for different clinical endpoint.
23Bioinformaticians Will Be Busy Bees
- Biomarkers discovery
- Rational design of small molecule inhibitors of
proteins - Mechanistic understanding of protein evolution
understanding exactly how new protein functions
evolve - Mechanistic understanding of speciation
molecular details of how speciation occurs - Continued development of effective gene
ontologies systematic ways to describe the
functions of gene or protein - Education development of appropriate
bioinformatics curricula for secondary,
undergraduate, and graduate education
24Atomic level enquiry Modelling/simulations Newtoni
an Quantum Brownian Imaginary!!
Links to Cheminformatics
25Bioinformaticians Will Be Busy Bees
- Biomarkers discovery
- Rational design of small molecule inhibitors of
proteins - Mechanistic understanding of protein evolution
understanding exactly how new protein functions
evolve - Mechanistic understanding of speciation
molecular details of how speciation occurs - Continued development of effective gene
ontologies systematic ways to describe the
functions of gene or protein - Education development of appropriate
bioinformatics curricula for secondary,
undergraduate, and graduate education
26Bioinformaticians Will Be Busy Bees
- Biomarkers discovery
- Rational design of small molecule inhibitors of
proteins - Mechanistic understanding of protein evolution
understanding exactly how new protein functions
evolve - Mechanistic understanding of speciation
molecular details of how speciation occurs - Continued development of effective gene
ontologies systematic ways to describe the
functions of gene or protein - Education development of appropriate
bioinformatics curricula for secondary,
undergraduate, and graduate education
27Bioinformaticians Will Be Busy Bees
- Biomarkers discovery
- Rational design of small molecule inhibitors of
proteins - Mechanistic understanding of protein evolution
understanding exactly how new protein functions
evolve - Mechanistic understanding of speciation
molecular details of how speciation occurs - Continued development of effective gene
ontologies systematic ways to describe the
functions of gene or protein - Education development of appropriate
bioinformatics curricula for secondary,
undergraduate, and graduate education
28BII Singapore - Vision
- To be a premier International BioInformatics
Institute by fostering and conducting
leading-edge informatics research, development,
and high quality training, to generate knowledge
from large diverse volumes of Biology and
Chemistry data
29BII Singapore - Mission
- Human Capital
- To foster high quality, innovative, and
multi-disciplinary research and post-graduate
training in BioInformatics - Intellectual Capital
- To create knowledge base and tools to manage, and
understand large, diverse biological and
chemistry datasets - To create Intellectual Property
- Industrial Capital
- To play an active role in Knowledge and
Technology transfer - Drug target
identification/validation, BioMarkers, etc.
30BII Focus Areas
Bioinformatics Institute
Information Science Systems
Research Development
Education
Comp. Biology
Ph. D. Training
NUS (NTU)
Systems Biology
SBCR
Masters Training
Medical (Clinical)
Information Science
JC Outreach
(Biomarkers)
MOE Teacher
Systems Infra
(Cheminformatics)
Custom Training
BioImaging
NG
31Bioinformatics Graduate Curriculum
- in association with the ASTAR Graduate
Scholarship (AGS) / NUS Graduate School (NGS)
schemes.
Coursework- intensive
Research
Post-Doc Training (2 years)
PhD
Year 1
Year 2
Year 3
Year 4
Qualifying Exam
Coursework components 12 modules (4MC each)
- Computational Biology 1 (BII)
- Computational Biology 2 (BII)
- Protein Classification Structure Prediction
(BII) - Systems Biology (BII)
- Mathematical Biology (BII)
- Research Ethics and Integrity I II (NUS)
- 6 Electives (NUS)
Electives in
Life Sciences Mathematics Probability
Statistics Computing I.T.
32SBCR
33BII
The Biopolis_at_one north
34(No Transcript)
35Our Home